Physician profile
Mark Connolly
NPI 1326010612
$48,138.65
in general payments reported to CMS, 2019-2025
18 companies · $9,931 in 2025
The $9,931 reported for 2025 was more than what 89% of Thoracic Surgery (Cardiothoracic Vascular Surgery) providers received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,748 · 2020: $927 · 2021: $6,006 · 2022: $2,786 · 2023: $3,821 · 2024: $17K · 2025: $9,931.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $28K · Food and Beverage: $1,639 · Travel and Lodging: $1,284.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $27,750.00 |
| Food and Beverage | $1,638.95 |
| Travel and Lodging | $1,283.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $31,791.38 | 2019-2025 | Xience V, Xience Skypoint, Epic |
| Livanova USA, INC. | $5,466.00 | 2019-2021 | |
| Atricure, INC. | $5,323.33 | 2019-2025 | Synergy Ablation System, Epi-Sense Guided Coagulation System With Visitrax, Atriclip Laa Exclusion System |
| Medtronic, INC. | $1,910.84 | 2021-2025 | Penditure, Corevalve Evolut R, Na |
| Medtronic Vascular, INC. | $1,706.14 | 2019-2020 | |
| Abiomed | $901.35 | 2019-2023 | Impella |
| Zimmer Biomet Holdings, INC. | $276.92 | 2022-2025 | A&E Medical / Sternalock Xp Rigid Fixation System, Sternalock |
| Edwards Lifesciences Corporation | $166.70 | 2022-2025 | Sapien 3 Ultra Resilia, Konect Resilia |
| Cook Medical LLC | $125.36 | 2021 | |
| Ethicon US, LLC | $124.69 | 2019 | |
| Edap Technomed INC | $78.00 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $77.03 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $65.79 | 2022-2023 | Lifevest |
| Getinge USA Sales, LLC | $47.39 | 2020 | |
| Novo Nordisk INC | $21.46 | 2024 | Wegovy |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $19.49 | 2020 | |
| Haemonetics Corporation | $19.38 | 2022 | |
| Polarityte, INC. | $17.40 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Connolly listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.